OABI Q1 2024 Earnings — OmniAb, Inc. Revenue & Financial Results | Market Cap Arena

OABIOmniAb, Inc.

$231M

Q1 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$4M-77.5% YoY

Gross Profit

$4M100.0% margin

Operating Income

-$23M-593.3% margin

Net Income

-$19M-498.8% margin

EPS (Diluted)

$-0.19

QoQ Revenue Growth

-21.2%

Cash Flow

Operating Cash Flow

-$17M

Free Cash Flow

-$18M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$353M

Total Liabilities

$51M

Stockholders' Equity

$301M

Cash & Equivalents

$19M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4M	$17M	-77.5%
Gross Profit	$4M	$13M	-69.7%
Operating Income	-$23M	-$8M	-168.4%
Net Income	-$19M	-$6M	-210.8%

Revenue Segments

Service

$3M90%

Royalty

$319,00010%